demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
secondary prevention
anticoagulant
rivaroxaban MICHELLE

1 studies excluded by filtering options 2

6405 Li [retracted], 2020 200excludedrisk of bias not avaialble